Princeton-based WIRB-Copernicus Group (WCG) announced on Tuesday its Executive Chairman and Chief Executive Officer Donald Deieso has been named one of the 100 Most Inspiring Leaders in the Life Science Industry by PharmaVOICE for the second time in less than five years, having previously earned this honor in 2016.
The PharmaVOICE 100 list, published annually, celebrates inspirational, motivational and transformative individuals in life sciences who positively impact their colleagues, peers, organizations, and the industry.
“Dr. Deieso’s passion for improving the clinical trial process and doing what’s right for patients — at all times — are truly inspiring,” said Taren Grom, editor of PharmaVOICE, in a statement.
“His never wavering integrity and human-centric approach to problem solving are just a few of the qualities that define him as a PharmaVOICE 100,” said Grom.
Deieso became executive chairman of WCG in 2012 and assumed the additional role of CEO in October 2013. Under Deieso’s leadership, WCG has grown 15 times in size.
“I am honored to be recognized by PharmaVOICE as one of the industry’s most inspiring leaders,” said Deieso. “I have enjoyed the opportunity to lead eight companies during my career. While each has been rewarding in many ways, building the WCG family of companies has been the most gratifying.
“Improving the clinical trial process for bringing new drugs to market has such a profound impact on so many lives. It is humbling to consider that the actions of WCG positively affect millions of lives through our involvement in each new drug or device. The scale of this endeavor exceeds what any single one of us can do,” Deieso said.
“Don is someone who leads by example,” said Dr. Jeffrey Litwin, WCG’s chief operating officer. “He holds himself to the highest standards of moral and ethical behavior, takes accountability for every decision he makes, and is the first to roll up his sleeves and pitch in during times of trouble. Don brings the very best of himself to work each day and demands no less from those around him.”
Deieso serves as an operating partner and co-head of the Healthcare Group at Arsenal Capital Partners, as well as a member of the board of directors for BioIVT, TractManager and Inspire. Previously, he served on the board of directors for Certara, Breckenridge Financial Services and IMDS.